• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.03% Nasdaq Up 0.17%

    Rexahn Pharmaceuticals, Inc. (RNN)

    -NYSE MKT
    0.71 Down 0.02(2.08%) Dec 24, 1:00PM EST
    Add to Portfolio
    Prev Close:0.72
    Open:0.71
    Bid:0.49 x 100
    Ask:0.92 x 100
    1y Target Est:3.17
    Beta:-0.8
    Next Earnings Date:N/A
    Day's Range:0.71 - 0.72
    52wk Range:0.44 - 1.85
    Volume:244,478
    Avg Vol (3m):861,969
    Market Cap:125.67M
    P/E (ttm):N/A
    EPS (ttm):-0.11
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for RNN

    Comparison

    Symbol% ChgMkt Cap
    RNNDown 2.08%125.67M
    GSKUp 0.26%103.01B
    PFEDown 0.10%197.97B
    RHHBYDown 0.03%232.93B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.11
    Quarterly EPS Est (Dec-14) :-0.02
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer. The company has three clinical stage oncology candidates: Archexin, RX-3117, and SupinoxinTM (RX-5902), as well as a pipel... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback